Technical Analysis for SNPX - Synaptogenix, Inc.

Grade Last Price % Change Price Change
F 2.60 -1.92% -0.05
SNPX closed up 10.0 percent on Wednesday, November 20, 2024, on 45 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.92%
Lower Bollinger Band Walk Weakness -1.92%
Inside Day Range Contraction -1.92%
Wide Bands Range Expansion -1.92%
Gapped Up Strength -1.92%
Oversold Stochastic Weakness -1.92%
Stochastic Buy Signal Bullish 7.88%
Lower Bollinger Band Walk Weakness 7.88%
Outside Day Range Expansion 7.88%
Wide Bands Range Expansion 7.88%

   Recent Intraday Alerts

Alert Time
Possible NR7 9 minutes ago
Possible Inside Day 9 minutes ago
Down 1% about 3 hours ago
Rose Above Lower Bollinger Band 1 day ago
Up 5% 1 day ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Synaptogenix, Inc. Description

Synaptogenix is a clinical-stage biopharmaceutical company that has historically worked to develop novel therapies for neurodegenerative diseases. Synaptogenix has conducted clinical and preclinical studies of its lead therapeutic candidate, Bryostatin-1, in Alzheimer's disease. Preclinical studies have also demonstrated Bryostatin's regenerative mechanisms of action for the rare disease, Fragile X syndrome, and for other neurodegenerative disorders such as multiple sclerosis, stroke, and traumatic brain injury. The U.S. Food and Drug Administration has granted Orphan Drug Designation to Synaptogenix for Bryostatin-1 as a treatment for Fragile X syndrome. Bryostatin-1 has already undergone testing in more than 1,500 people in cancer studies, thus creating a large safety data base that will further inform clinical trial designs.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Biology Neuroscience Rare Diseases Alzheimer's Disease Neurodegenerative Diseases Multiple Sclerosis Stroke Amyotrophic Lateral Sclerosis Neurodegeneration Neurodegenerative Disorders Fragile X Syndrome Traumatic Brain Injury

Is SNPX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.775
52 Week Low 2.32
Average Volume 23,406
200-Day Moving Average 4.05
50-Day Moving Average 3.01
20-Day Moving Average 2.89
10-Day Moving Average 2.75
Average True Range 0.24
RSI (14) 43.18
ADX 16.43
+DI 20.22
-DI 22.68
Chandelier Exit (Long, 3 ATRs) 2.81
Chandelier Exit (Short, 3 ATRs) 3.04
Upper Bollinger Bands 3.39
Lower Bollinger Band 2.39
Percent B (%b) 0.26
BandWidth 34.49
MACD Line -0.16
MACD Signal Line -0.11
MACD Histogram -0.0466
Fundamentals Value
Market Cap 54.06 Million
Num Shares 20.4 Million
EPS -0.85
Price-to-Earnings (P/E) Ratio -3.12
Price-to-Sales 0.00
Price-to-Book 0.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.93
Resistance 3 (R3) 2.90 2.77 2.88
Resistance 2 (R2) 2.77 2.70 2.79 2.87
Resistance 1 (R1) 2.71 2.66 2.74 2.74 2.85
Pivot Point 2.59 2.59 2.60 2.60 2.59
Support 1 (S1) 2.53 2.52 2.56 2.56 2.45
Support 2 (S2) 2.40 2.48 2.42 2.44
Support 3 (S3) 2.34 2.40 2.42
Support 4 (S4) 2.37